+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Drugs By Therapeutic Area Market Research Reports

From
From
From
From
From
From
From
From
From
From
Substance Use Disorder Treatment: Global Markets to 2030 - Product Thumbnail Image

Substance Use Disorder Treatment: Global Markets to 2030

  • Report
  • June 2026
  • 116 Pages
  • Global
From
Cardiovascular Drugs: Global Markets to 2030 - Product Thumbnail Image

Cardiovascular Drugs: Global Markets to 2030

  • Report
  • April 2026
  • 178 Pages
  • Global
From
From
Cannabis Market: Products, Technologies, and Applications - Product Thumbnail Image

Cannabis Market: Products, Technologies, and Applications

  • Report
  • January 2026
  • 131 Pages
  • Global
From
GLP-1 Analogues Market - Product Thumbnail Image

GLP-1 Analogues Market

  • Report
  • December 2025
  • 85 Pages
  • Global
From
Hyaluronic Acid in Healthcare: Global Markets - Product Thumbnail Image

Hyaluronic Acid in Healthcare: Global Markets

  • Report
  • September 2025
  • 114 Pages
  • Global
From
Neurodermatitis Epidemiology Forecast 2026-2035 - Product Thumbnail Image

Neurodermatitis Epidemiology Forecast 2026-2035

  • Report
  • May 2026
  • 100 Pages
  • Global
From
Optic Nerve Diseases Epidemiology Forecast 2026-2035 - Product Thumbnail Image

Optic Nerve Diseases Epidemiology Forecast 2026-2035

  • Report
  • May 2026
  • 100 Pages
  • Global
From
From
From
Loading Indicator

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more